Description

The fund's core objective is to achieve substantial growth in capital over an extended timeframe. Typically, at least 80% of its total assets are committed to equity investments in companies globally involved in the healthcare industry, with selections made by its sub-adviser, Wellington Management Company LLP. The investment strategy adopts a comprehensive view of the healthcare sector, encompassing a diverse range of enterprises. These may include, but are not limited to, firms specializing in pharmaceuticals, biotechnology, medical device manufacturing and distribution, healthcare service provision, managed health programs, health information technology, and nascent health-related segments.